| [1] |
Gazdar AF, Minna JD. Multifocal lung cancers—clonality vs field cancerization and does it matter？[J] J Natl Cancer Inst，2009，101(8)：541-543.
|
| [2] |
Ishigaki T, Yoshimasu T, Oura S, et al. Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer[J]. Ann Thorac Cardiovasc Surg，2013，19(5)：341-344.
|
| [3] |
Flieder DB, Vazquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening[J]. Am J Surg Patho，2006，30(5)：606-613.
|
| [4] |
Tanvetyanon T, Finley DJ, Fabian T, et al. Prognostic factors for survival after complete resections of synchronous lung cancers in multiple lobes: pooled analysis based on individual patient data[J]. Ann Oncol, 2013，24(4)：889-894.
|
| [5] |
Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours[J]. J Thorac Oncol, 2007，2(8)：706-714.
|
| [6] |
Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin[J]. Cancer，1953；6(5)：963-968.
|
| [7] |
Strong MS, Incze J, Vaughan CW. Field cancerization in the aerodigestive tract—its etiology, manifestation, and significance[J]. J Otolaryngol, 1984，13(1)：1-6.
|
| [8] |
Johnson BE, Cortazar P, Chute JP. Second lung cancers in patients successfully treated for lung cancer[J]. Semin Oncol，1997，24(4)：492-499.
|
| [9] |
Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients[J]. Cancer Res，2005，65(17)：7568-7572.
|
| [10] |
Wang X, Wang M, MacLennan GT, et al. Evidence for common clonal origin of multifocal lung cancers[J]. J Natl Cancer Inst, 2009，101(8)：560-570.
|
| [11] |
Martini N, Melamed MR. Multiple primary lung cancers[J]. J Thorac Cardiovasc Surg, 1975，70(4)：606-612.
|
| [12] |
Shen KR, Meyers BF, Larner JM, et al, American College of Chest P. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)[J]. Chest，2007，132(3 Suppl)：290S-305S.
|
| [13] |
Chang YL, Wu CT, Lin SC, et al. Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers[J]. Clin Cancer Res, 2007，13(1)：52-58.
|
| [14] |
Girard N, Deshpande C, Azzoli CG, et al. Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines[J]. Chest，2010，137(1)：46-52.
|
| [15] |
Arai J, Tsuchiya T, Oikawa M, et al. Clinical and molecular analysis of synchronous double lung cancers[J]. Lung Cancer，2012，77(2)：281-287.
|
| [16] |
Takamochi K, Oh S, Matsuoka J, et al. Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras[J]. Lung Cancer, 2012，75(3)：313-320.
|
| [17] |
Warth A, Macher-Goeppinger S, Muley T, et al. Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy[J]. Eur Res J, 2012，39(6)：1437-1442.
|
| [18] |
Girard N, Deshpande C, Lau C, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases[J]. Am J Surg Pathol, 2009，33(12)：1752-1764.
|
| [19] |
Girard N, Ostrovnaya I, Lau C, et al. Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers[J]. Clin Cancer Res，2009，15(16)：5184-5190.
|
| [20] |
Matsuzoe D, Hideshima T, Ohshima K，et al. Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation[J]. British J Cancer，1999，79(9-10)：1549-1552.
|
| [21] |
Murphy SJ, Aubry MC, Harris FR, et al. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer[J]. J Clin Oncol, 2014，32(36)：4050-4058.
|
| [22] |
Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib[J]. N Engl J Med, 2004，350(21)：2129-2139.
|
| [23] |
Li C, Fang R, Sun Y, et al. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers[J]. PLoS One, 2011，6(11)：e28204.
|
| [24] |
Sun Y, Ren Y, Fang Z, et al. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases[J]. J Clin Oncol，2010，28(30)：4616-4620.
|
| [25] |
Zhang Y, Hu H, Wang R, et al. Synchronous non-small cell lung cancers: diagnostic yield can be improved by histologic and genetic methods[J]. Ann Surg Oncol, 2014，21(13)：4369-4374.
|
| [26] |
Yatabe Y, Matsuo K, Mitsudomi T. Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma[J]. J Clin Oncol, 2011，29(22)：2972-2977.
|
| [27] |
Asamura H. Multiple primary cancers or multiple metastases, that is the question[J]. J Thorac Oncol，2010，5(7)：930-931.
|
| [28] |
Kim HK, Choi YS, Kim K, et al. Management of ground-glass opacity lesions detected in patients with otherwise operable non-small cell lung cancer[J]. J Thorac Oncol，2009，4(10)：1242-1246.
|
| [29] |
Trousse D, Barlesi F, Loundou A, et al. Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management[J]. J Thorac Cardiovasc Surg, 2007, 133(5): 1193-1200.
|